PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Gedeon Richter
GR

Gedeon Richter

UK public-sector supplier
SME

Gedeon Richter Plc. is an innovation-driven specialty pharmaceutical company headquartered in Hungary, involved in pharmaceutical manufacturing, research and development, sales, and marketing. The company focuses on women's healthcare, biosimilars, and offers a wide range of pharmaceutical products.

gedeonrichter.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£208.6m
Live
9
Buyers
5
12m
£208.6m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts9 / 13
  • Top buyers5
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Gedeon RichterUpdated 13 Jul 2026

At a glance · for buyers and watchdogs

Gedeon Richter has won £208.6m across 5 public-sector buyers, with 9 live contracts.

Why: top buyer NHS England at 89% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
No CH recordCompany status
9 of 13Live contracts
89%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Sectors served · 1/8
Central government✓
Local government✓
NHS & health✓
Housing✓
Utilities & energy✓
Financial services✓
Education✓
Defence✓
Services · 3
Pharmaceutical ManufacturingInvolves the production of original, generic, and licensed pharmaceutical products.
Research and DevelopmentFocuses on the research of new chemical entities and innovative therapies.
Sales and MarketingInvolves the promotion and distribution of pharmaceutical products.

Extracted automatically from gedeonrichter.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 9 live · 4 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
NHS England—01 Sept 2026£166.3m2 yrspending
Ustekinumab
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)—01 Oct 2026£6.5m1.8 yrspending
Transitional Drugs 7
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)—01 Jul 2026£16.8m2 yrspending
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
NHS England—01 Sept 2026£18.9m12 mopending
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
NHS England————Live
Transitional Drugs 7
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)————Live
NP39823 Gastro Intestinal, Endocrine, Nutrition & Blood Medicine
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)33600000———Live
NP36722 Fertility Products
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)33600000———Live
Proprietary Drugs
eTenderwales————Live
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
NHS England————Live
Total live value — · mean award £16.0m1–10 of 13

Top buyers · 5 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
4 contracts
89%
since 2026
2
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
3 contracts
11%
since 2026
3
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
4 contracts
0%
4
eTenderwales
1 contract
0%
5
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
1 contract
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire4 contracts
89%
Wales5 contracts
11%
Scotland4 contracts
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Gedeon Richter highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
GR
Gedeon Richter
Yes£208.6m—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m22
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m12
TA
Thornton and Ross Ltd
Yes£72.5m12
AC
ACCORD-UK LTD
Yes£71.2m21
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
No Companies House record linked — automated risk checks unavailable.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
No Companies House record linked — statutory compliance checks unavailable.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Registered details, directors and PSC.

✓ Live sync
🏛

No Companies House record linked

No Companies House number on file — this supplier may be overseas, a sole trader or a consortium.

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
—
— · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.